bioMérieux

bioMérieux

Pesquisa biotecnológica

Marcy-l'Étoile, Auvergne-Rhône-Alpes 325.363 seguidores

Pioneering Diagnostics

Sobre nós

Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP

Site
https://www.biomerieux.com
Setor
Pesquisa biotecnológica
Tamanho da empresa
de 10.001 funcionários
Sede
Marcy-l'Étoile, Auvergne-Rhône-Alpes
Tipo
Empresa de capital aberto
Fundada em
1963
Especializações
in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank e sepsis

Localidades

Funcionários da bioMérieux

Atualizações

Páginas afiliadas

Páginas semelhantes

Visualizar vagas